HuGE Literature Finder
Records 1-30
|
Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
World journal of gastroenterology 2019 Jul 25 (26): 3408-3425. Wu Jing-Bo, Sarmiento Ali Lopez, Fiset Pierre-Olivier, Lazaris Anthula, Metrakos Peter, Petrillo Stephanie, Gao Zu-H |
|
Correlations between P53 Mutation Status and Texture Features of CT Images for Hepatocellular Carcinoma.
Methods of information in medicine 2019 Jun . Wu Hongzhen, Chen Xin, Chen Jiawei, Luo Yuqi, Jiang Xinqing, Wei Xinhua, Tang Wenjie, Liu Yu, Liang Yingying, Liu Weifeng, Guo Yu |
|
Early prediction of liver carcinogenicity due to occupational exposure to pesticides.
Mutation research 2019 Feb 838 46-53. Saad-Hussein Amal, Beshir Safia, Taha Mona M, Shahy Eman M, Shaheen Weam, Abdel-Shafy Ebtesam A, Thabet Em |
|
Near-comprehensive resequencing of cancer-associated genes in surgically resected metastatic liver tumors of gastric cancer.
The American journal of pathology 2019 Jan . Ikari Naoki, Serizawa Akiko, Mitani Shohei, Yamamoto Masakazu, Furukawa To |
|
Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection.
Journal of surgical oncology 2019 Jan 119 (1): 40-46. Huang Jianbo, Wang Xiangyu, Zhu Ying, Wang Zheng, Li Jianhua, Xu Da, Wang Shenghao, Li Tian-En, Lu |
|
Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Clinical colorectal cancer 2018 Jul . Khan Maliha, Loree Jonathan M, Advani Shailesh M, Ning Jing, Li Wen, Pereira Allan A L, Lam Michael, Raghav Kanwal, Morris Van K, Broaddus Russell, Maru Dipen, Overman Michael J, Kopetz Sco |
|
Analysis of Tissue and Circulating Tumor DNA by Next-Generation Sequencing of Hepatocellular Carcinoma: Implications for Targeted Therapeutics.
Molecular cancer therapeutics 2018 May 17 (5): 1114-1122. Ikeda Sadakatsu, Lim Jordan S, Kurzrock Razel |
|
The clinical implications of G1-G6 transcriptomic signature and 5-gene score in Korean patients with hepatocellular carcinoma.
BMC cancer 2018 May 18 (1): 571. Ahn Sung-Min, Haq Farhan, Park Inkeun, Nault Jean-Charles, Zucman-Rossi Jessica, Yu Euns |
|
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
BMC cancer 2018 01 18 (1): 11. Huemer Florian, Thaler Josef, Piringer Gudrun, Hackl Hubert, Pleyer Lisa, Hufnagl Clemens, Weiss Lukas, Greil Richa |
|
TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population
Asian Pacific journal of cancer prevention : APJCP 2017 Dec 18 (12): 3423-3427. Asadi Milad, Shanehbandi Dariush, Zarintan Armin, Pedram Negar, Baradaran Behzad, Zafari Venus, Shirmohamadi Masoud, Hashemzadeh Shahriy |
|
Prevalence of Aflatoxin-associated TP53R249S mutation in Hepatocellular Carcinoma in Hispanics in South Texas.
Cancer prevention research (Philadelphia, Pa.) 2017 Oct . Jiao Jingjing, Niu Weibo, Wang Ying, Baggerly Keith A, Ye Yuanqing, Wu Xifeng, Davenport Dewitt, Almeda Jose Luis, Betancourt-Garcia Monica M, Forse R Armour, Stevenson Heather L, Watt Gordon P, McCormick Joseph B, Fisher-Hoch Susan P, Beretta Lau |
|
Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.
Medicine 2017 Sep 96 (36): e7856. Duan Xiaohua, Li Jingqu |
|
Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype.
Journal of the National Cancer Institute 2017 Sep 109 (9): . Hong Theodore S, Wo Jennifer Y, Borger Darrell R, Yeap Beow Y, McDonnell Erin I, Willers Henning, Blaszkowsky Lawrence S, Kwak Eunice L, Allen Jill N, Clark Jeffrey W, Tanguturi Shyam, Goyal Lipika, Murphy Janet E, Wolfgang John A, Drapek Lorraine C, Arellano Ronald S, Mamon Harvey J, Mullen John T, Tanabe Kenneth K, Ferrone Cristina R, Ryan David P, Iafrate A John, DeLaney Thomas F, Zhu Andrew |
|
Tumor heterogeneity predicts metastatic potential in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Sep . Joung Je-Gun, Oh Bo Young, Hong Hye Kyung, AlKhalidi Hisham, Al-Alem Faisal, Lee Hae-Ock, Bae Joon Seol, Kim Jinho, Cha Hong-Ui, Alotaibi Maram, Cho Yong Beom, Hassanain Mazen, Lee Woo Yong, Park Woong-Ya |
|
Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
Annals of surgery 2017 Aug . Chun Yun Shin, Passot Guillaume, Yamashita Suguru, Nusrat Maliha, Katsonis Panagiotis, Loree Jonathan M, Conrad Claudius, Tzeng Ching-Wei D, Xiao Lianchun, Aloia Thomas A, Eng Cathy, Kopetz Scott E, Lichtarge Olivier, Vauthey Jean-Nicol |
|
ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.
Oncology reports 2017 Jul . Zhu Guangzhi, Liao Xiwen, Han Chuangye, Liu Xiaoguang, Yu Long, Qin Wei, Lu Sicong, Su Hao, Chen Zhiwei, Liu Zhengtao, Liang Yu, Huang Jianlu, Yu Tingdong, Yang Chengkun, Huang Ketuan, Shang Liming, Ye Xinping, Li Lequn, Qin Xue, Xiao Kaiyin, Peng Minhao, Peng T |
|
Genome-Wide Association Study of MKI67 Expression and its Clinical Implications in HBV-Related Hepatocellular Carcinoma in Southern China.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2017 Jul 42 (4): 1342-1357. Yang Cheng-Kun, Yu Ting-Dong, Han Chuang-Ye, Qin Wei, Liao Xi-Wen, Yu Long, Liu Xiao-Guang, Zhu Guang-Zhi, Su Hao, Lu Si-Cong, Chen Zhi-Wei, Liu Zhen, Huang Ke-Tuan, Liu Zheng-Tao, Liang Yu, Huang Jian-Lu, Mo Zeng-Nan, Qin Xue, Li Lequn, Xiao Kai-Yin, Peng Min-Hao, Winkle Cheryl Ann, O'Brien Stephen J, Peng T |
|
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 1015-1022. Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Murgioni S, Rossini D, Marmorino F, Mennitto A, Ning Y, Okazaki S, Berger M D, Miyamoto Y, Gopez R, Barzi A, Yamaguchi T, Loupakis F, Lenz H |
|
Genetic Features of Aflatoxin-associated Hepatocellular Carcinomas.
Gastroenterology 2017 Mar . Zhang Weilong, He Huan, Zang Mengya, Wu Qifeng, Zhao Hong, Lu Ling-Ling, Ma Peiqing, Zheng Hongwei, Wang Nengjin, Zhang Ying, He Siyuan, Chen Xiaoyan, Wu Zhiyuan, Wang Xiaoyue, Cai Jianqiang, Liu Zhihua, Sun Zongtang, Zeng Yi-Xin, Qu Chunfeng, Jiao Yuch |
|
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.
Oncology reports 2017 Mar . Ye Song, Zhao Xin-Yi, Hu Xiao-Ge, Li Tang, Xu Qiu-Ran, Yang Huan-Ming, Huang Dong-Sheng, Yang L |
|
Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology 2017 Feb . Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Murgioni S, Rossini D, Marmorino F, Mennitto A, Ning Y, Okazaki S, Berger M D, Miyamoto Y, Gopez R, Barzi A, Yamaguch T, Loupakis F, Lenz H |
|
Mutation location on the RAS oncogene effects pathologic features and survival after resection of colorectal liver metastases.
Cancer 2016 Oct . Frankel Timothy L, Vakiani Efsevia, Nathan Hari, DeMatteo Ronald P, Kingham T Peter, Allen Peter J, Jarnagin William R, Kemeny Nancy E, Solit David B, D'Angelica Michael |
|
Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Molecular cancer 2016 Oct 15 (1): 63. Kovaleva Valentina, Geissler Anna-Lena, Lutz Lisa, Fritsch Ralph, Makowiec Frank, Wiesemann Sebastian, Hopt Ulrich T, Passlick Bernward, Werner Martin, Lassmann Sil |
|
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
Oncotarget 2016 Sep 7 (38): 61575-61586. van Ginkel Joost H, de Leng Wendy W J, de Bree Remco, van Es Robert J J, Willems Stefan |
|
TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
International journal of cancer 2016 Aug . Ki Kim Soo, Ueda Yoshihide, Hatano Etsuro, Kakiuchi Nobuyuki, Takeda Haruhiko, Goto Tomoyuki, Shimizu Takahiro, Yoshida Kenichi, Ikura Yoshihiro, Shiraishi Yuichi, Chiba Kenichi, Tanaka Hiroko, Miyano Satoru, Uemoto Shinji, Chiba Tsutomu, Ogawa Seishi, Marusawa Hiroyu |
|
Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
Lung cancer (Amsterdam, Netherlands) 2016 Jun 96 52-5. Bonanno Laura, Calabrese Fiorella, Nardo Giorgia, Calistri Daniele, Tebaldi Michela, Tedaldi Gianluca, Polo Valentina, Vuljan Stefania, Favaretto Adolfo, Conte PierFranco, Amadori Alberto, Rea Federico, Indraccolo Stefa |
|
Differences in somatic mutation landscape of hepatocellular carcinoma in Asian American and European American populations.
Oncotarget 2016 May . Yao Song, Johnson Christopher, Hu Qiang, Yan Li, Liu Biao, Ambrosone Christine B, Wang Jianmin, Liu So |
|
Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing.
Oncotarget 2016 May . Liao Wenjun, Yang Huayu, Xu Haifeng, Wang Yanan, Ge Penglei, Ren Jinjun, Xu Wei, Lu Xin, Sang Xinting, Zhong Shouxian, Zhang Hongbing, Mao Yil |
|
Detection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence.
Advances in experimental medicine and biology 2016 924 25-28. García-Fernández N, Macher Hada C, Rubio Amalia, Jiménez-Arriscado Pilar, Bernal-Bellido C, Bellido-Díaz M L, Suárez-Artacho G, Guerrero Juan M, Gómez-Bravo M A, Molinero Patrocin |
|
EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.
Scientific reports 2016 08 6 31237. Han Chuangye, Liao Xiwen, Qin Wei, Yu Long, Liu Xiaoguang, Chen Gang, Liu Zhengtao, Lu Sicong, Chen Zhiwei, Su Hao, Zhu Guangzhi, Lu Zili, Liu Zhiming, Qin Xue, Gui Ying, Mo Zengnan, Li Lequn, Peng T |
|
Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis.
PloS one 2016 11 (7): e0159636. Liu Jiangbo, Li Wei, Deng Miao, Liu Dechun, Ma Qingyong, Feng Xiaosh |
|
Prognostic value of DNA repair based stratification of hepatocellular carcinoma.
Scientific reports 2016 6 25999. Lin Zhuo, Xu Shi-Hao, Wang Hai-Qing, Cai Yi-Jing, Ying Li, Song Mei, Wang Yu-Qun, Du Shan-Jie, Shi Ke-Qing, Zhou Meng-T |
|
Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Oct . Qiu Moqin, Liu Yingchun, Yu Xiangyuan, Qin Linyuan, Bei Chunhua, Zeng Xiaoyun, Qiu Xiaoqiang, Tang Bo, He Songqing, Yu Hongpi |
|
Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.
Oncotarget 2015 Sep 6 (26): 22179-90. Lim Byungho, Mun Jihyeob, Kim Jeong-Hwan, Kim Chan Wook, Roh Seon Ae, Cho Dong-Hyung, Kim Yong Sung, Kim Seon-Young, Kim Jin Che |
|
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection.
Cancer genetics 2015 Jul . Saitta Carlo, Lanza Marika, Bertuccio Antonio, Lazzara Salvatore, Navarra Giuseppe, Raimondo Giovanni, Pollicino Tere |
|
[I148M polymorphism of PNPLA3 gene affects cell cycle of hepatoma carcinoma cell Huh-7].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2015 May 23 (5): 328-32. Geng Ning, Jiang Man, Zhang Ding-Ding, Wang Jian, Xin Yong-Ning, Xuan Shi-Yi |
|
Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 Research Group study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015 May 41 (5): 683-9. Pilat N, Grünberger T, Längle F, Mittlböck M, Perisanidis B, Kappel S, Wolf B, Starlinger P, Kührer I, Mühlbacher F, Kandioler |
|
The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Liver international : official journal of the International Association for the Study of the Liver 2015 Mar 35 (3): 999-1009. Qi Lu-Nan, Bai Tao, Chen Zu-Shun, Wu Fei-Xiang, Chen Yuan-Yuan, De Xiang Bang-, Peng Tao, Han Ze-Guang, Li Le-Q |
|
Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.
Bulletin du cancer 2015 Feb 102 (2): 117-25. Netter Jeanne, Lehmann-Che Jacqueline, Lambert Jerome, Tallet Anne, Lourenco Nelson, Soliman Hany, Bertheau Philippe, Pariente Benjamin, Chirica Mircea, Pocard Marc, Allez Matthieu, De The Hugues, Gornet Jean-Ma |
|
Association between polymorphisms in tumor suppressor genes and oncogenes and risk of hepatocellular carcinoma: a case-control study in an HCC epidemic area within the Han Chinese population.
Medical oncology (Northwood, London, England) 2014 Dec 31 (12): 356. Su Chenghao, Lin Yong, Niu Jianjun, Cai L |
|
Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.
Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
|
The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Apr 35 (4): 3647-56. Hu Surong, Zhao Lianying, Yang Jingting, Hu Mi |
|
Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
Molecular nutrition & food research 2014 Feb 58 (2): 329-42. Kuo Chang-Sheng, Huang Chi-Yun, Kuo Hsing-Tao, Cheng Chin-Pao, Chen Chien-Hung, Lu Chin-Li, Yang Feili-Lo, Syu Huang Rwei-F |
|
Preliminary monocentric results of biological characteristics of pregnancy associated breast cancer.
Breast (Edinburgh, Scotland) 2014 Feb 23 (1): 19-25. Michieletto Silvia, Saibene Tania, Evangelista Laura, Barbazza Franco, Grigoletto Raffaello, Rossi Giovanna, Ghiotto Cristina, Bozza Fernan |
|
Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.
PloS one 2014 9 (7): e100854. Zhang Yuannv, Qiu Zhaoping, Wei Lin, Tang Ruqi, Lian Baofeng, Zhao Yingjun, He Xianghuo, Xie |
|
Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
Annals of surgical oncology 2013 Dec 20 Suppl 3 S537-44. Ishibashi Masahisa, Kogo Ryunosuke, Shibata Kohei, Ueo Hiroki, Uchi Ryutaro, Matsumura Tae, Takano Yuki, Sawada Genta, Takahashi Yusuke, Mima Kousuke, Kurashige Junji, Akiyoshi Sayuri, Iwaya Takeshi, Eguchi Hidetoshi, Sudo Tomoya, Sugimachi Keishi, Suzuki Akira, Wakabayashi Go, Mori Masaki, Mimori Kos |
|
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
Hepatology (Baltimore, Md.) 2013 Nov 58 (5): 1693-702. Cleary Sean P, Jeck William R, Zhao Xiaobei, Chen Kui, Selitsky Sara R, Savich Gleb L, Tan Ting-Xu, Wu Michael C, Getz Gad, Lawrence Michael S, Parker Joel S, Li Jinyu, Powers Scott, Kim Hyeja, Fischer Sandra, Guindi Maha, Ghanekar Anand, Chiang Derek |
|
Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma.
Genes, chromosomes & cancer 2013 Oct 52 (10): 912-9. Ortiz-Cuaran Sandra, Cox David, Villar Stéphanie, Friesen Marlin D, Durand Geoffroy, Chabrier Amélie, Khuhaprema Thiravud, Sangrajrang Suleeporn, Ognjanovic Simona, Groopman John D, Hainaut Pierre, Le Calvez-Kelm Floren |
|
Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
Epidemiology (Cambridge, Mass.) 2013 Sep 24 (5): 671-81. Long Xi-Dai, Zhao Dong, Wang Chao, Huang Xiao-Ying, Yao Jin-Guang, Ma Yun, Wei Zhong-Hua, Liu Min, Zeng Li-Xiao, Mo Xiao-Qiang, Zhang Jian-Jun, Xue Feng, Zhai Bo, Xia Qia |
|
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
Genome research 2013 Sep 23 (9): 1422-33. Kan Zhengyan, Zheng Hancheng, Liu Xiao, Li Shuyu, Barber Thomas D, Gong Zhuolin, Gao Huan, Hao Ke, Willard Melinda D, Xu Jiangchun, Hauptschein Robert, Rejto Paul A, Fernandez Julio, Wang Guan, Zhang Qinghui, Wang Bo, Chen Ronghua, Wang Jian, Lee Nikki P, Zhou Wei, Lin Zhao, Peng Zhiyu, Yi Kang, Chen Shengpei, Li Lin, Fan Xiaomei, Yang Jie, Ye Rui, Ju Jia, Wang Kai, Estrella Heather, Deng Shibing, Wei Ping, Qiu Ming, Wulur Isabella H, Liu Jiangang, Ehsani Mariam E, Zhang Chunsheng, Loboda Andrey, Sung Wing Kin, Aggarwal Amit, Poon Ronnie T, Fan Sheung Tat, Wang Jun, Hardwick James, Reinhard Christoph, Dai Hongyue, Li Yingrui, Luk John M, Mao M |
|
Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.
Molecular biology reports 2013 Aug 40 (8): 4883-7. de Carvalho Fernanda Magri, de Almeida Pereira Thiago, Gonçalves Patrícia Lofego, Jarske Robson Dettmann, Pereira Fausto Edmundo Lima, Louro Iuri Drumo |
|
Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Genomics 2013 Aug 102 (2): 74-83. Tornesello Maria Lina, Buonaguro Luigi, Tatangelo Fabiana, Botti Gerardo, Izzo Francesco, Buonaguro Franco |
|
Somatic changes in primary liver cancer in Russia: a pilot study.
Mutation research 2013 Aug 755 (2): 90-9. Kalinina Olga, Marchio Agnès, Urbanskii Aleksandr I, Tarkova Aleksandra B, Rebbani Khadija, Granov Dmitri A, Dejean Anne, Generalov Mikhail I, Pineau Pasc |
|
Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection.
Oncology reports 2013 Jul 30 (1): 119-24. Long Jiang, Wang Yan, Li Man, Tong Wei-Min, Jia Ji-Dong, Huang Ji |
|
Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
Gene 2013 Jul 524 (2): 156-60. Son Myung Su, Jang Moon Ju, Jeon Young Joo, Kim Won Hee, Kwon Chang-Il, Ko Kwang Hyun, Park Pil Won, Hong Sung Pyo, Rim Kyu Sung, Kwon Sung Won, Hwang Seong Gyu, Kim Nam Ke |
|
Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Jun 34 (3): 1451-9. Lv Long, Wang Ping, Zhou Xiaoqing, Sun Beiche |
|
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Oncogene 2013 Jun 32 (25): 3091-100. Wang P, Dong Q, Zhang C, Kuan P-F, Liu Y, Jeck W R, Andersen J B, Jiang W, Savich G L, Tan T-X, Auman J T, Hoskins J M, Misher A D, Moser C D, Yourstone S M, Kim J W, Cibulskis K, Getz G, Hunt H V, Thorgeirsson S S, Roberts L R, Ye D, Guan K-L, Xiong Y, Qin L-X, Chiang D |
|
Overexpression of Hypoxia Inducible Factor-1 Alpha is an Independent Risk Factor for Recurrence After Curative Resection of Colorectal Liver Metastases.
Annals of surgical oncology 2013 Jun . Shimomura M, Hinoi T, Kuroda S, Adachi T, Kawaguchi Y, Sasada T, Takakura Y, Egi H, Okajima M, Tashiro H, Nishizaka T, Ohdan H |
|
KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.
Cancer 2013 May 119 (9): 1669-74. Hsu Maylee, Sasaki Motoko, Igarashi Saya, Sato Yasunori, Nakanuma Yasu |
|
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy.
Oncotarget 2013 May 4 (5): 705-14. Said Rabin, Hong David S, Warneke Carla L, Lee J Jack, Wheler Jennifer J, Janku Filip, Naing Aung, Falchook Gerald S, Fu Siqing, Piha-Paul Sarina, Tsimberidou Apostolia M, Kurzrock Razel |
|
The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Annals of surgical oncology 2013 Apr 20 (4): 1395-402. Takatsuno Yasushi, Mimori Koshi, Yamamoto Ken, Sato Tetsuya, Niida Atsushi, Inoue Hiroshi, Imoto Seiya, Kawano Shuhei, Yamaguchi Rui, Toh Hiroyuki, Iinuma Hisae, Ishimaru Shinya, Ishii Hideshi, Suzuki Sadao, Tokudome Shinkan, Watanabe Masahiko, Tanaka Jun-Ichi, Kudo Shin-Ei, Mochizuki Hidetaka, Kusunoki Masato, Yamada Kazutaka, Shimada Yasuhiro, Moriya Yoshihiro, Miyano Satoru, Sugihara Kenichi, Mori Masa |
|
Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population.
Digestive diseases and sciences 2013 Mar 58 (3): 759-67. Mohana Devi Subramaniam, Balachandar Vellingiri, Arun Meyyazhagan, Suresh Kumar Shanmugam, Balamurali Krishnan Balasubramanian, Sasikala Keshavar |
|
Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.
Protein & cell 2013 Jan 4 (1): 1. Yang Y, Xia T, Li N, Zhang J, Yang Y, Cong W, Deng Q, Lan K, Zhou W |
|
Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (6): 3555-9. Thongbai Chureeporn, Sa-nguanmoo Pattaratida, Kranokpiruk Pavanrat, Poovorawan Kittiyod, Poovorawan Yong, Tangkijvanich Pis |
|
Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
Asian Pacific journal of cancer prevention : APJCP 2013 14 (12): 7675-9. Chittmittrapap Salyavit, Chieochansin Thaweesak, Chaiteerakij Roongruedee, Treeprasertsuk Sombat, Klaikaew Naruemon, Tangkijvanich Pisit, Komolmit Piyawat, Poovorawan Yo |
|
S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.
PloS one 2013 8 (6): e65501. Yuan Ray-Hwang, Chang Ko-Tung, Chen Yu-Ling, Hsu Hey-Chi, Lee Po-Huang, Lai Po-Lin, Jeng Yung-Mi |
|
TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
PloS one 2013 8 (12): e82773. Peng Qiliu, Lao Xianjun, Chen Zhiping, Lai Hao, Deng Yan, Wang Jian, Mo Cuiju, Sui Jingzhe, Wu Junrong, Zhai Limin, Yang Shi, Qin Xue, Li Sh |
|
Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.
Cancer letters 2012 Nov . Ortiz-Cuaran S, Villar S, Gouas D, Ferro G, Plymoth A, Khuhaprema T, Kalalak A, Sangrajrang S, Friesen MD, Groopman JD, Hainaut P |
|
Association Between TP53 Arg72Pro Polymorphism and Hepatocellular Carcinoma Risk: A Meta-analysis.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (9): 9. Xu CT, Zheng F, Dai X, Du JD, Liu HR, Zhao L, Li WM |
|
TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
Carcinogenesis 2012 Jun 33 (6): 1219-24. Gouas Doriane A, Villar Stphanie, Ortiz-Cuaran Sandra, Legros Pénélope, Ferro Gilles, Kirk Gregory D, Lesi Olufunmilayo A, Mendy Maimuna, Bah Ebrima, Friesen Marlin D, Groopman John, Chemin Isabelle, Hainaut Pier |
|
p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
Molecular biology reports 2012 Feb 39 (2): 1639-47. Sümbül Ahmet Taner, Akk?z Hikmet, Bayram Süleyman, Bekar Aynur, Akgöllü Ersin, Sand?kç? Mac |
|
Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
PloS one 2012 7 (6): e37707. Villar Stephanie, Ortiz-Cuaran Sandra, Abedi-Ardekani Behnoush, Gouas Doriane, Nogueira da Costa Andre, Plymoth Amelie, Khuhaprema Thiravud, Kalalak Anant, Sangrajrang Suleeporn, Friesen Marlin D, Groopman John D, Hainaut Pier |
|
TP53 codon 72 polymorphism with hepatocellular carcinoma: a metaanalysis.
The Journal of international medical research 2012 40 (2): 446-54. Ding C, Yu H, Yu H, Qin |
|
Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Liver international : official journal of the International Association for the Study of the Liver 2011 Oct 31 (9): 1366-72. Shirabe Ken, Toshima Takeo, Taketomi Akinobu, Taguchi Kennichi, Yoshizumi Tomoharu, Uchiyama Hideaki, Harimoto Norifumi, Kajiyama Kiyoshi, Egashira Akinori, Maehara Yoshihi |
|
Depicting the role of TP53 in hepatocellular carcinoma progression.
Journal of hepatology 2011 Sep 55 (3): 724-5. Villanueva Augusto, Hoshida Yuj |
|
Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
Gastroenterology 2011 Mar 140 (3): 1063-70. Woo Hyun Goo, Wang Xin Wei, Budhu Anuradha, Kim Yun Hee, Kwon So Mee, Tang Zhao-You, Sun Zongtang, Harris Curtis C, Thorgeirsson Snorri |
|
Hepatitis B virus-associated hepatocellular carcinoma from India: role of viral genotype and mutations in CTNNB1 (beta-catenin) and TP53 genes.
Journal of gastrointestinal cancer 2011 Mar 42 (1): 20-5. Vivekanandan Perumal, Torbenson Michael, Ramakrishna Banumat |
|
p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.
World journal of gastroenterology : WJG 2011 Mar 17 (9): 1211-8. Chen Xi, Liu Fei, Li Bo, Wei Yong-Gang, Yan Lv-Nan, Wen Tian- |
|
Role of p53 and ?-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2011 Feb 15 (2): 321-9. Yuan Ray-Hwang, Jeng Yung-Ming, Hu Rey-Heng, Lai Po-Lin, Lee Po-Huang, Cheng Chia-Chi, Hsu Hey-C |
|
A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
International journal of cancer. Journal international du cancer 2011 Jan 128 (2): 412-7. Xu Yan, Liu Li, Liu Jibin, Zhang Yixin, Zhu Jian, Chen Jianguo, Liu Sheng, Liu Zheng, Shi Haibin, Shen Hongbing, Hu Zhib |
|
The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.
Journal of gastrointestinal cancer 2010 Sep 41 (3): 185-9. Ozdemir Filiz Türe, Tiftikci Arzu, Sancak Seda, Eren Fatih, Tahan Veysel, Ak?n Hakan, Gündüz Feyza, Kedrah Ala Eldeen, Ustünda? Yücel, Av?ar Erol, Tözün Nurdan, Ozdo?an Osm |
|
Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.
The American journal of pathology 2010 Feb 176 (2): 1006-17. Dongiovanni Paola, Fracanzani Anna Ludovica, Cairo Gaetano, Megazzini Chiara Paola, Gatti Stefano, Rametta Raffaela, Fargion Silvia, Valenti Lu |
|
Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma.
Mutation research 2010 Feb 684 (1-2): 106-8. Acun Tolga, Terzio?lu-Kara Ece, Konu Ozlen, Ozturk Mehmet, Yakicier Mustafa Ceng |
|
Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma.
Histology and histopathology 2009 Oct 24 (10): 1223-32. Chiu Mei-Miao, Ko Ying-Ju, Tsou Ann-Ping, Chau Gar-Yang, Chau Yat-Pa |
|
TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 May 18 (5): 1638-43. Szymañska Katarzyna, Chen Jian-Guo, Cui Yan, Gong Yun Yun, Turner Paul Craig, Villar Stéphanie, Wild Christopher Paul, Parkin Donald Maxwell, Hainaut Pier |
|
249 TP53 mutation has high prevalence and is correlated with larger and poorly differentiated HCC in Brazilian patients.
BMC cancer 2009 9 (1): 204. Nogueira Jeronimo A, Ono-Nita Suzane K, Nita Marcelo E, de Souza Marcelo M T, do Carmo Eliane P, Mello Evandro S, Scapulatempo Cristovan, Paranaguá-Vezozzo Denise C, Carrilho Flair J, Alves Venancio A |
|
Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.
Journal of Zhejiang University. Science. B 2008 Nov 9 (11): 847-52. Zhu Zhong-Zheng, Liu Bing, Wang Ai-Zhong, Jia Hang-Ruo, Jin Xia-Xiang, He Xiang-Lei, Hou Li-Fang, Zhu Guan-Sh |
|
K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Aug 14 (15): 4830-5. Etienne-Grimaldi Marie-Christine, Formento Jean-Louis, Francoual Mireille, François Eric, Formento Patricia, Renée Nicole, Laurent-Puig Pierre, Chazal Maurice, Benchimol Daniel, Delpero Jean-Robert, Letoublon Christian, Pezet Denis, Seitz Jean-François, Milano Géra |
|
MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Carcinogenesis 2008 Jun 29 (6): 1192-6. Yoon Young Joon, Chang Hye Young, Ahn Sang Hoon, Kim Ja Kyung, Park Yong Kwang, Kang Dae Ryong, Park Jun Yong, Myoung Sung Min, Kim Do Young, Chon Chae Yoon, Han Kwang-Hy |
|
Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma.
Cancer letters 2008 May 263 (2): 212-22. Liu Zhi-Ming, Li Le-Qun, Peng Min-Hao, Liu Tang-Wei, Qin Zhong, Guo Ya, Xiao Kai-Yin, Ye Xin-Ping, Mo Xin-Shao, Qin Xue, Li Shan, Yan Lu-Nan, Shen Han-Ming, Wang LianWen, Wang Qiao, Wang Kai-bo, Liang Ren-xiang, Wei Zong-liang, Ong Choon Nam, Santella Regina M, Peng T |
|
[Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2008 Apr 25 (2): 168-71. Wang Ai-zhong, Zhu Zhong-zheng, Cong Wen-mi |
|
Polymorphism of XRCC1 and the frequency of mutation in codon 249 of the p53 gene in hepatocellular carcinoma among Guangxi population, China.
Molecular carcinogenesis 2008 Apr 47 (4): 295-300. Long Xi Dai, Ma Yun, Huang Hong Dong, Yao Jin Guang, Qu De Ying, Lu Yun Lo |
|
Telomere length in hepatocellular carcinoma and paired adjacent non-tumor tissues by quantitative PCR.
Cancer investigation 2007 Dec 25 (8): 668-77. Zhang Yujing, Shen Jing, Ming-Whei , Lee Yu Po-Huang, Santella Regina |
|
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection.
Carcinogenesis 2007 Jun 28 (6): 1241-6. Molleví David G, Serrano Teresa, Ginestà Mireia M, Valls Joan, Torras Jaume, Navarro Matilde, Ramos Emilio, Germà Josep R, Jaurrieta Eduardo, Moreno Víctor, Figueras Joan, Capellà Gabriel, Villanueva Alber |
|
Prognosis in patients with hepatocellular carcinoma correlates to mutations of p53 and/or hMSH2 genes.
European journal of cancer (Oxford, England : 1990) 2007 Apr 43 (6): 1092-100. Yano Masatsugu, Hamatani Kiyohiro, Eguchi Hidetaka, Hirai Yuko, MacPhee Donald G, Sugino Keizo, Dohi Kiyohiko, Itamoto Toshiyuki, Asahara Toshima |
|
[Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2005 Dec 22 (6): 632-5. Zhu Zhong-zheng, Cong Wen-ming, Zhu Guan-shan, Liu Shu-fang, Xian Zhi-hong, Wu Wei-qing, Zhang Xiu-zhong, Wang Yan-hua, Wu Meng-ch |
|
A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
Cancer letters 2005 Nov 229 (1): 77-83. Zhu Zhong-Zheng, Cong Wen-Ming, Liu Shu-Fang, Xian Zhi-Hong, Wu Wei-Qing, Wu Meng-Chao, Gao Bin, Hou Li-Fang, Zhu Guan-Sh |
|
Absence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposure.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Aug 14 (8): 2053-5. Turner Paul C, Sylla Abdoulaye, Kuang Shuang-Yuan, Marchant Clare L, Diallo Mamadou S, Hall Andrew J, Groopman John D, Wild Christopher |
|
Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Feb 14 (2): 380-4. Kuang Shuang-Yuan, Lekawanvijit Suree, Maneekarn Niwat, Thongsawat Satawat, Brodovicz Kimberly, Nelson Kenrad, Groopman John |
|
[p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhonghua yi xue za zhi 2005 Jan 85 (2): 76-9. Zhu Zhong-Zheng, Cong Wen-Ming, Liu Shu-Fang, Dong Hui, Zhu Guan-Shan, Wu Meng-Ch |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: